Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Perrigo Company

Perrigo Company
1887 FOUNDED
PUBLIC STATUS
10K-15K EMPLOYEES
PRGO STOCK SYMBOL
41 INVESTMENTS
$59.02 SHARE PRICE (As of Friday Closing)
Description

Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
NYS
Primary Office
  • The Sharp Building
  • Hogan Place
  • Dublin 2
  • Ireland

+353 (01) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Perrigo Company’s full profile, request a free trial.

Perrigo Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$40.68 - $60.23 $8.03B $59.51 $1.80 1.11M 136M

Perrigo Company Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 10,172,094 8,085,641 15,192,677 17,458,427
Revenue 4,709,800 4,731,700 4,946,200 5,280,600
EBITDA 925,200 842,200 893,000 (4,174,700)
Net Income 246,500 131,000 119,600 (4,012,800)
Total Assets 11,310,800 10,983,400 11,628,800 13,870,100
Total Debt 3,500,100 3,242,400 3,341,200 5,797,300
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Perrigo Company Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.

Request full access to PitchBook

Perrigo Company Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Knight Therapeutics Corporation Montreal, Canada 00
000000 00000 Corporation Mumbai, India 0000
00000 Corporation Hatfield, United Kingdom 00000 00.00 000000&0 00.00
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
000000 Corporate Backed or Acquired Holzkirchen, Germany 00000 00000000000
To view this company’s complete list of competitors, request access »

Perrigo Company Investments & Acquisitions (41)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 00000 06-Jan-2020 000000000 00000 00 Buildings and Property 000000 0000000
00000000 0000 02-Dec-2019 000000000 00000 00 Buildings and Property
00000 01-Jul-2019 000000000000000000 00000 Medical Supplies 000000 0000000
00000 000000000000 27-Apr-2018 000000000 00000 00 Buildings and Property
Geiss, Destin & Dunn 17-Aug-2016 Merger/Acquisition Personal Products 0000 00000000000
To view this company’s complete investment and acquisition history, request access »

Perrigo Company Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 0000000000 01-Jan-2003 000000000000000000 Completed
  • 0000000 0000000
Vi-Jon 01-Dec-1994 Merger/Acquisition 0000 Completed
To view this company’s complete exits history, request access »

Perrigo Company Subsidiaries (7)

Company Name Industry Location Founded
Vedants Drugs and Fine Chemicals Pharmaceuticals Mumbai, India 2004
00000, 000000 & 00 Personal Products Peachtree City, GA 0000
00000 000000 Personal Products Nazareth, Belgium 0000
0000000 000000000 Pharmaceuticals Balcatta, Australia 0000
00000 Medical Supplies Grand Rapids, MI 0000
To view this company’s complete subsidiary history, request access »

Perrigo Company Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.

Request full access to PitchBook

Perrigo Company Executive Team (29)

Name Title Board
Seat
Contact
Info
Murray Kessler Chief Executive Officer & Board Member
Jeffrey Needham Executive Vice President & President
Sharon Kochan Executive Vice President & President
Raymond Silcock Chief Financial Officer & Chief Accounting Officer
Thomas Farrington Chief Information Officer & Executive Vice President

16 Former Executives

You’re viewing 5 of 29 executives. Get the full list »

Perrigo Company Board Members (7)

Name Representing Role Since Contact
Info
0000000 0000000000 Self Board Member 000 0000
0000000 000000 Perrigo Company Board Member 000 0000
00000000 000000 Self Board Member 000 0000
0000000 0000000 00 Self Board Member 000 0000
000000 0000000 Perrigo Company Chief Executive Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »